The hyperglycemic effect of S-nitrosoglutathione in the dog

Nitric Oxide - Biology and Chemistry

Volumn 3, Issue 6, 1999, Pages 481-491

  McGowder, Donovan ^a   Ragoobirsingh, Dalip ^a   Dasgupta, Tara ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRITE; S NITROSOGLUTATHIONE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DOG; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033370921     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1999.0254     Document Type: Article

References (27)

1. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
2. Nathan C., Xie Q-R. Regulation of the biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
3. Burkart V., Kronche K. D., Brenner H. H., Kolb H., Kolb-Bachofen V. Nitric oxide is a pathogenic factor in type 1 diabetes. Diabetologia. 34:1991;A95.
4. Rabinovitch A. Immunoregulatory and cytokine inbalances in the pathogenesis of IDDM. Diabetes. 43:1994;613-621.
5. Kowaluk E. A., Fung H. Spontaneous liberation of nitric oxide cannot account or in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255:1990;1256-1264.
6. Clancy R. M., Levartovartovsky D., Leszczynska-Piziak J., Yegudin J., Abrahamson S. B. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: Evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA. 91:1994;3680-3684.
7. Matthews W. R., Kerr S. W. Biological activity of S-nitrosothiols: The role of nitric oxide. J. Pharmacol. Exp. Ther. 267:1993;1529-1537.
8. Park J. W., Billman G. E., Means G. E. Transnitrosation as a predominant mechanism in the hypotensive effect of S-nitrosoglutathione. Biochem. Mol. Biol. Int. 30:1993;885-891.
9. Radomski M. W., Rees D. D., Dutra A., Moncada S. inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107:1992;745-749.
10. de Belder A. J., MacAllister R., Radomski M. W., Moncada S. Effects of S-nitrosoglutathione in the human forearm circulation: Evidence for selective platelet activation. Cardiovasc. Res. 28:1994;691-694.
11. Langford E. J., Brown R. J., de Belder A. J., Thomas M. R., Radomski M. W., Martin J. F. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 344:1994;1458-1460.
12. Hart T. W. Some observations concerning the S-nitroso and S-phenylsulfonyl derivatives of l-cysteine and glutathione. Tetrahedron Lett. 26:1985;2013-2016.
13. Huggertt A. St. G., Nixon D. A. Use of glucose oxidase, peroxidase, and o-dianisidine in determination of blood and urinary glucose. The Lancet. 314:1957;368-370.
14. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
15. Rett K., Wicklmayer M., Dietze G. Hypoglycaemia in hypertensive diabetic patients treated with sulfonylureas, biguanidines, and captopril. N. Engl. J. Med. 319:1988;1609.
16. Winocur P., Waldek S., Anderson D. C. Captopril and blood glucose. Lancet. 2:1986;461.
17. Mosen H., Salehi A., Lundquist I. Islet acid glucan-1,4-α-glucosidase in relation to nitric oxide and insulin secretion. Diabetologia. 41:1997;A 110.
18. Young M. E., Radda G. K., Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 322:1997;223-228.
19. Schmidt H. H. W., Warner T. D., Ishii K., Sheng H., Murad F. Insulin secretion from pancreatic B cells caused by l-arginine-derived nitrogen oxides. Science. 255:1992;721-723.
20. Eizirik D. L., Sandler S., Welsh N., Hellerstrom C. Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology. 122:1988;1242-1249.
21. Turk J., Corbett J. A., Romanadham S., Bohrer A., McDaniel M. L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 1997:1993;1458-1464.
22. Groop L. C., Bonadonna R. C., Del Prato S., Ratheiser K., Zyck K., Ferrannini E., DeFronzo R. A. Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus: Evidence for multiple sites of insulin resistance. J. Clin. Invest. 84:1989;205-213.
23. Karpen C. W., Pritchard K. A., Arnold J. H. Restoration of the prostacyclin/thromboxane A2 balance in the diabetic rat. Influence of vitamin E. Diabetes. 31:1982;947-951.
24. Collier A., Wilson R., Bradley H. Free radical activity in type-2 diabetes. Diabetic Med. 7:1990;27-30.
25. Pieper G. M., Gross G. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic aorta. Am. J. Physiol. 255:1988;H825-H833.
26. Smith, J. N, and, Dasgupta, T. P. 1997, The mechanism of nitric oxide release from nitrovasodilators. Proceedings of the Annual Research Conference, Faculty of Medical Sciences, University of the West Indies, Mona. PP-#01.
27. Wennmalm A., Benthin G., Petersson A. S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br. J. Pharmacol. 106:1992;507-508.